🧫Microbial Pathogens

This section is for bacteria-focused pathogen content with oncology relevance.

The first live section is Fusobacterium nucleatum (Fn).

That focus matters because Fn keeps appearing in cancer discussions around biofilms, oral sources, immune evasion, and treatment resistance.

Current focus

Current content covers:

• oral source burden

• tumour targeting

• gut ecology

• antimicrobial options

• berberine

• EGCG and related polyphenols

• L. reuteri as a targeted support organism

What will expand next

This section can house:

• bacterial overviews with cancer-specific relevance

• cancer-type breakdowns for key pathogens

• oral and gut source discussions

• biofilm-focused support pages

• testing and interpretation pages

• remediation-adjacent protocol notes

• clinician-supervised support pages

The next planned additions are Fn by cancer type pages and a full L. reuteri deep dive.

This section is educational only. Testing, antimicrobial treatment, and remediation decisions need clinician oversight.

This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.

© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.